167 related articles for article (PubMed ID: 8105937)
1. Vitamin D therapy in CAPD: what is its role?
Hutchison AJ; Gokal R
Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G
Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
5. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
6. Control of mineral metabolism in CAPD patients.
Delmez JA
Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
Yalçinkaya F; Ince E; Tümer N; Ensari A; Ozkaya N
Pediatr Int; 2000 Feb; 42(1):53-7. PubMed ID: 10703235
[TBL] [Abstract][Full Text] [Related]
8. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients.
Juergensen P; Santacroce S; Mooraki A; Cooper K; Finkelstein FO; Kliger AS
Adv Perit Dial; 1994; 10():259-60. PubMed ID: 7999840
[TBL] [Abstract][Full Text] [Related]
9. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J
Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024
[TBL] [Abstract][Full Text] [Related]
10. Differences in calcium kinetic pattern between CAPD and HD patients.
Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
[TBL] [Abstract][Full Text] [Related]
11. [Renal osteodystrophy and growth in children undergoing CAPD].
Ito T; Horiike S; Iitaka K
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
[TBL] [Abstract][Full Text] [Related]
12. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
Hutchison AJ; Freemont AJ; Boulton HF; Gokal R
Nephrol Dial Transplant; 1992; 7(12):1219-25. PubMed ID: 1337163
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
Jüppner H; Hoyer PF; Latta K; Winkler L; Offner G; Brodehl J
Pediatr Nephrol; 1990 Nov; 4(6):614-7. PubMed ID: 2088463
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
[TBL] [Abstract][Full Text] [Related]
15. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
16. Renal osteodystrophy in dialyzed children.
Salusky IB; Goodman WG
Miner Electrolyte Metab; 1991; 17(4):273-80. PubMed ID: 1813790
[TBL] [Abstract][Full Text] [Related]
17. Renal osteodystrophy and aluminum bone disease in CAPD patients.
Gokal R
Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
[TBL] [Abstract][Full Text] [Related]
18. Renal osteodystrophy.
Kanis JA; Cundy TF; Hamdy NA
Baillieres Clin Endocrinol Metab; 1988 Feb; 2(1):193-241. PubMed ID: 3044329
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
[TBL] [Abstract][Full Text] [Related]
20. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
